BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1284777)

  • 1. [Prevalence of Borrelia burgdorferi antibodies in Hamburg blood donors].
    Weiland T; Kühnl P; Laufs R; Heesemann J
    Beitr Infusionsther; 1992; 30():92-5. PubMed ID: 1284777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Infections with Borrelia burgdorferi in Würzburg blood donors: antibody prevalence, clinical aspects and pathogen detection in antibody positive donors].
    Böhme M; Schembra J; Bocklage H; Schwenecke S; Fuchs E; Karch H; Wiebecke D
    Beitr Infusionsther; 1992; 30():96-9. PubMed ID: 1284778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Borrelia burgdorferi (strain B. afzelii) antibodies among Malaysian blood donors and patients.
    Tay ST; Kamalanathan M; Rohani MY
    Southeast Asian J Trop Med Public Health; 2002 Dec; 33(4):787-93. PubMed ID: 12757227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymerase chain reaction in diagnosis of Borrelia burgdorferi infections and studies on taxonomic classification.
    Lebech AM
    APMIS Suppl; 2002; (105):1-40. PubMed ID: 11985118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serologic evaluation of occurrence in Poland of Lyme disease caused by infection with Borrelia burgdorferi].
    Tylewska-Wierzbanowska S; Kruszewska D
    Med Dosw Mikrobiol; 1993; 45(4):487-91. PubMed ID: 8189829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiologic, ecologic and clinical characteristics of Lyme borrelliosis in northwest Croatia.
    Golubić D; Rijpkema S; Tkalec-Makovec N; Ruzić E
    Acta Med Croatica; 1998; 52(1):7-13. PubMed ID: 9599811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Retrospective study of a borreliosis infected blood donor].
    Weiland T; Kühnl P; Darda C; Sibrowski W; Pulz M
    Beitr Infusionsther; 1991; 28():32-4. PubMed ID: 1725647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparable evaluation of serological diagnostic tests (ELISA, IFA and PA methods) for the detection of anti-Borrelia burgdorferi antibody].
    Miyamoto S; Takemura Y; Hanba Y; Kitani A; Ishizuka T; Suzuki K; Sekiguchi S
    Rinsho Byori; 1992 Nov; 40(11):1204-9. PubMed ID: 1307628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroprevalence of antibodies to Borrelia burgdorferi in a population of horses in central Texas.
    Cohen ND; Heck FC; Heim B; Flad DM; Bosler EM; Cohen D
    J Am Vet Med Assoc; 1992 Oct; 201(7):1030-4. PubMed ID: 1429127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevalence of Borrelia burgdorferi serum antibodies in 651 patients with predominantly neurologic diseases].
    Müller M; Retzl J; Plank E; Scholz H; Ziervogel H; Stanek G
    Wien Klin Wochenschr; 1993; 105(21):599-602. PubMed ID: 8273357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Incidence of antibodies to Borrelia burgdorferi in dogs in small animal practice in North Bavaria].
    Weber A; Heim U; Schäfer R
    Berl Munch Tierarztl Wochenschr; 1991 Nov; 104(11):384-6. PubMed ID: 1772393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A limitation of 2-stage serological testing for Lyme disease: enzyme immunoassay and immunoblot assay are not independent tests.
    Wormser GP; Carbonaro C; Miller S; Nowakowski J; Nadelman RB; Sivak S; Aguero-Rosenfeld ME
    Clin Infect Dis; 2000 Mar; 30(3):545-8. PubMed ID: 10722442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of borreliacidal antibodies by flow cytometry. An accurate, highly specific serodiagnostic test for Lyme disease.
    Callister SM; Schell RF; Lim LC; Jobe DA; Case KL; Bryant GL; Molling PE
    Arch Intern Med; 1994 Jul; 154(14):1625-32. PubMed ID: 8031211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevalence of Lyme borreliosis in The Netherlands].
    Nohlmans MK; van den Bogaard AE; Blaauw AA; van Boven CP
    Ned Tijdschr Geneeskd; 1991 Nov; 135(48):2288-92. PubMed ID: 1749435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lyme disease: seroprevalence and vector survey in southern Alberta.
    Anand CM; Fonseca K; Stowe T; Olson M; Wallis P
    Can Commun Dis Rep; 1993 Dec; 19(24):205-9. PubMed ID: 8148785
    [No Abstract]   [Full Text] [Related]  

  • 16. [Are seroprevalence studies useful in Lyme disease?].
    Díaz-Míguez D; Fernández-Fernández F; Sesma P; Rodríguez-Mayo MD
    Enferm Infecc Microbiol Clin; 1993 Oct; 11(8):460-1. PubMed ID: 8260522
    [No Abstract]   [Full Text] [Related]  

  • 17. The prevalence of antibodies against B. burgdorferi, an indicator for Lyme borreliosis in dogs? A comparison of serological tests.
    Goossens HA; Maes JH; van den Bogaard AE
    Tijdschr Diergeneeskd; 2003 Nov; 128(21):650-7. PubMed ID: 14650723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Incidence of Borrelia burgdorferi in the Greifswald area of the Vorpommern region of the Mecklenburg-Vorpommern district].
    Oheim S; Herrmann H
    Z Arztl Fortbild (Jena); 1994 Oct; 88(10):807-10. PubMed ID: 7825362
    [No Abstract]   [Full Text] [Related]  

  • 19. The prevalence of Borrelia burgdorferi seropositivity in an area endemic for Lyme disease.
    Jochimsen E; Sikkink J; Marx JJ
    Wis Med J; 1990 Dec; 89(12):677-81. PubMed ID: 2293487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Risk factors associated with the presence of antibodies against Borrelia burgdorferi].
    Arteaga Pérez F; García-Moncó Carra JC
    Rev Clin Esp; 1999 Mar; 199(3):136-41. PubMed ID: 10230291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.